9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. (2021)

First Author: Han G

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-25894-9

PubMed Identifier: 34556668

Publication URI: http://europepmc.org/abstract/MED/34556668

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723